MedTrace Logo

A Study to Evaluate the Effect of SlimBiotics Probiotic Formula on Weight Management and Metabolic Health Outcomes

NCT05917314 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2024-08-23

No results posted yet for this study

Summary

This study is to evaluate the efficacy of a probiotic supplement on weight management and metabolic health. This study will be conducted as a hybrid trial consisting of both in-person visits and virtual assessments. Two groups will be included: the intervention (SlimBiotics Probiotic) and placebo.

The SlimBiotics probiotic formula is the first plant-based probiotic targeting weight management and metabolic health. Other competing probiotics are isolated from humans (feces) but the strains in SlimBiotics were isolated from a fermented plant (millet porridge cereal).

This product contains 3 probiotic strains:

Limosilactobacillus fermentum K7-Lb1 Limosilactobacillus fermentum K8-Lb1 Limosilactobacillus fermentum K11-Lb3

Conditions

  • Metabolic Health
  • Weight Loss
  • Stress
  • Well-Being, Psychological
  • Sleep
  • Healthy Eating

Interventions

OTHER

Slimbiotic Probiotic

SlimBiotics Probiotic formula contains three probiotic strains of L. fermentum: * Limosilactobacillus fermentum K7-Lb1 * Limosilactobacillus fermentum K8-Lb1 * Limosilactobacillus fermentum K11-Lb3 The product also contains Microcrystalline cellulose.

OTHER

Placebo

The placebo capsule contains microcrystalline cellulose.

Sponsors & Collaborators

  • Citruslabs

    collaborator INDUSTRY

  • Slimbiotics

    lead UNKNOWN

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2023-11-24
Completion
2023-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05917314 on ClinicalTrials.gov